Not applicableUnknownNCT02992990What this trial is testingBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeWho this might be right forBladder Cancer Baylor College of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT04383743What this trial is testingPembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder CancerWho this might be right forStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma University of Washington 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02845323What this trial is testingNeoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the BladderWho this might be right forUrothelial CarcinomaBladder Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Not applicableAvailableNCT06443944What this trial is testingAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGWho this might be right forNon-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more CG Oncology, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07414992What this trial is testingRadiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder CancerWho this might be right forBladder Urothelial Carcinoma Memorial Sloan Kettering Cancer Center 44
Not applicableUnknownNCT05276167What this trial is testingHyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaWho this might be right forHigh-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications Henan Cancer Hospital 40
Not applicableActive Not RecruitingNCT05779592What this trial is testingEvaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial CarcinomaWho this might be right forMuscle-invasive Urothelial Carcinoma Bristol-Myers Squibb 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT02447549What this trial is testingStudy of Tumour Focused Radiotherapy for Bladder CancerWho this might be right forBladder Cancer Institute of Cancer Research, United Kingdom 345
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07639983What this trial is testingMulti-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial CarcinomaWho this might be right forMuscle-Invasive Bladder Cancer (MIBC)Urinary Bladder Cancer Sheng Tai 44
Testing effectiveness (Phase 2)Looking for participantsNCT06682728What this trial is testingAdjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk RecurrenceWho this might be right forUrothelial CarcinomaMuscle-invasive Bladder Cancer University of California, Irvine 23
Large-scale testing (Phase 3)Ended earlyNCT04197986What this trial is testingOral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic AlterationsWho this might be right forUpper Tract Urothelial CarcinomasUrothelial Bladder Cancer QED Therapeutics, a BridgeBio company 39
Very early researchStudy completedNCT03473730What this trial is testingDaratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerWho this might be right forBladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more M.D. Anderson Cancer Center 17
Not applicableLooking for participantsNCT06991868What this trial is testingProspective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Who this might be right forNMIBCMIBCUTUC Peking University First Hospital 300
Testing effectiveness (Phase 2)Study completedNCT05226117What this trial is testingSacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder CancerWho this might be right forUrothelial Carcinoma IRCCS San Raffaele 44
Not applicableUnknownNCT05503563What this trial is testingA Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary BladderWho this might be right forBladder Cancer Assiut University 50
Not applicableStudy completedNCT01224665What this trial is testingS1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder CancerWho this might be right forBladder Cancer SWOG Cancer Research Network 658
Testing effectiveness (Phase 2)UnknownNCT04730232What this trial is testingTilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableWho this might be right forHigh-RiskNon-Muscle Invasive Bladder Urothelial Carcinoma Tianjin Medical University Second Hospital 63
Not applicableStudy completedNCT04872036What this trial is testingPrognostic Biomarkers in Patients With Urothelial CarcinomaWho this might be right forBladder Cancer Hellenic Cooperative Oncology Group 66
Large-scale testing (Phase 3)Active Not RecruitingNCT03775265What this trial is testingChemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder CancerWho this might be right forBladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more National Cancer Institute (NCI) 475
Testing effectiveness (Phase 2)Study completedNCT03914794What this trial is testingPemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsWho this might be right forBladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30